Topics covered: Valuation, The real estate market, The long-term potential, The insulin delivery device, The consumer product model, Sustainable Investing, social and governance (ESG) criteria, Safe and effective therapies, Reasonable prices, Quality companies, Product integrity, New Opportunities, Governance practices, Future growth, Environmental, Drug interactions, Diversity, Diabetes-related issues, Chinese companies